{
    "clinical_study": {
        "@rank": "93890", 
        "arm_group": [
            {
                "arm_group_label": "AKI group", 
                "description": "patients with AKI after cardiopulmonary bypass surgery"
            }, 
            {
                "arm_group_label": "non-AKI group", 
                "description": "patients without AKI during study period"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the utility of plasma cystatin C(pCysC) as a predictive and diagnostic marker of\n      acute kidney injury(AKI) in patients undergone cardiopulmonary bypass surgery."
        }, 
        "brief_title": "Plasma Cystatin C and Acute Kidney Injury", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Kidney Injury", 
        "condition_browse": {
            "mesh_term": [
                "Acute Kidney Injury", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a prospective AKI observational study in patients undergone cardiopulmonary bypass\n      surgery. pCysC and plasma creatine will be measured at entry to ICU.AKI was defined as 50%\n      increase in plasma creatine above baseline.The predictive and diagnostic performance of\n      pCysC will be assessed from area under receiver operator characteristic curve(AUC) and odds\n      ratio(OR)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with CPB and admitted to ICU\n\n        Exclusion Criteria:\n\n          -  patients with the age >80 or <18 years\n\n          -  with preexisting renal dysfunction"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients undergone cardiopulmonary bypass surgery"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01652755", 
            "org_study_id": "N-H-Y"
        }, 
        "intervention_browse": {
            "mesh_term": "Cystatins"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "cystatin C,acute kidney injury,", 
        "lastchanged_date": "August 3, 2012", 
        "location": {
            "contact": {
                "email": "nihongying2@163.com", 
                "last_name": "Hongying Ni, MM", 
                "phone": "86", 
                "phone_ext": "57982552629"
            }, 
            "facility": {
                "address": {
                    "city": "Jinhua", 
                    "country": "China", 
                    "state": "Zhejiang", 
                    "zip": "321000"
                }, 
                "name": "Jinhua central hospital"
            }, 
            "investigator": {
                "last_name": "Hongying Ni, MM", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "official_title": "Use of Cystatin C in Predicting AKI in Patients Undergone Cardiopulmonary Bypass Surgery", 
        "overall_contact": {
            "email": "nihongying2@163.com", 
            "last_name": "Hongying Ni, MM", 
            "phone": "86", 
            "phone_ext": "57982552629"
        }, 
        "overall_official": {
            "affiliation": "Jinhua municipal central hospital", 
            "last_name": "Hongying Ni, MM", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01652755"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Jinhua Central Hospital", 
            "investigator_full_name": "Hongying Ni", 
            "investigator_title": "Department vice director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Jinhua Central Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Jinhua Central Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2011", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2012"
    }
}